In this study, we showed that both deletion of FIP200 and specifically disrupting its autophagy function abrogated the development of malignant LAS from the benign LM lesions, suggesting that inhibiting autophagy could potentially prevent tumorigenesis (rather than induce it) for this deadly disease. Here, RB1CC1 is linked to lymphangioma.